Terns Pharmaceuticals, Inc. (TERN)

40.08 -0.51 (-1.26%) USD  |  NASDAQ  |  Dec 31, 14:38
More

Terns Pharmaceuticals Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade